MPG.eBooks - Search Results

Cover Image

1481

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1482

Clinical review report: Indacaterol/mometasone furoate (Atectura Breezhaler) : (Novartis Pharmaceuticals Canada Inc.) : indication : asthma maintenance (adults, children 12 or olde...

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

1483

Clinical review report: Halobetasol propionate and tazarotene (Duobrii) : (Bausch Health, Canada Inc.) : indication : psoriasis, moderate-to-severe plaque

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1484

CADTH Canadian drug expert committee recommendation: Erenumab (Aimovig -- Novartis pharmaceuticals Canada Inc.) : indication: prevention of migraine

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1485

Body weight modification interventions for chronic non-cancer pain : a review of clinical effectiveness

by Li, Yan, Argáez, Charlene
Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1486

Clinical review report: Glucagon nasal powder (Baqsimi) (Eli Lilly Canada Inc) : indication: for the treatment of severe hypoglycemic reactions which may occur in the management of...

Published 2020

CADTH

Cover Image

1487

Clinical review report: Apomorphine (Movapo) (Paladin Labs, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

1488

Migalastat (Galafold) (Amicus therapeutics)

Published 2018

CADTH

Cover Image

1489

Monitoring for atrial fibrillation in discharged stroke and transient ischemic attack patients: A clinical and cost-effectiveness analysis and review of patient preferences

by De Angelis, Gino
Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

1490

Self-collected versus clinician collected samples for sexually transmitted infection testing in women : a review of comparative clinical effectiveness cost-effectiveness, and guide...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

1491

Clinical review report: Telotristat (Xermelo) (Ipsen Biopharmaceuticals Canada Inc.)

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

1492

Pharmacoeconomic review report: Brexpiprazole (Rexulti) : (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.) : indication: treatment of schizophrenia in adults

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

1493

MRI-compatible ventilators and physiological equipment for adults undergoing MRI exams : a review of clinical effectiveness and guidelines

by Islam, Saadul, Argáez, Charlene
Published 2018

CADTH

Cover Image

1494

Clinical review report: Cerliponase Alfa (Brineura) (Biomarin Pharmaceutical (Canada) Inc.) : indication : for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2) disease...

Published 2019

CADTH

Cover Image

1495

Vaginal micronized progesterone capsules for the prevention of miscarriage and preterm birth : a review of the clinical evidence

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

1496

Ingenol mebutate (Picato) : topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

1497

CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

1498

Fluoroquinolone prescribing and use in Canadian primary care practice

by Crain, Janet, MacPherson, Jennifer, Raj, Michael, Singh, Kavita
Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

1499

Rifaximin (Zaxine) : for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients > 18 years of age

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

1500

Clinical review report: Obeticholic acid (Ocaliva) : (Intercept Pharmaceuticals Canada, Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

70
71
72
73
74
75
76
77
78
79
80